Prof. Dr Luke P. Lee, Harvard Medical School & Brigham and Women’s Hospital. He is founding director of the Biomedical Institute for Global Health Research and Technology (BIGHEART) at the National University of Singapore. Lee has over 350 peer-reviewed publications and over 40 issued international patents. He is a pioneer in bionanophotonics, plasmonic resonant energy transfer (PRET), rapid photonic PCR, optofluidics, microfluidics for quantitative life sciences, and integrated molecular diagnostics systems. He was elected Fellow of the Royal Society of Chemistry in 2010 and the American Institute of Medical and Biological Engineering in 2012. Lee received the 2009 IEEE William J. Morlock Award and the 2010 “Ho-Ann Prize” for his discovery of PRET and the development of quantum nanobiophotonics for optical gene regulations and molecular imaging. His current research interests are quantum electron transfers in living organisms, molecular diagnostics of infectious and neurodegenerative diseases, and in vitro neurogenesis, with a focus both on studying fundamental quantum nanobiology and on solving ill-defined problems of global importance.